Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibition.

Autor: Frank FM; Instituto de Investigaciones en Microbiología y Parasitología Médica, Facultad de Medicina, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (IMPaM, UBA-CONICET), Buenos Aires, Argentina., Wagner DH Jr; Webb-Waring Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA., Postan M; Instituto Nacional de Parasitología 'Dr. Mario Fatala Chabén', ANLIS/Malbran, Buenos Aires, Argentina., Petray PB; Instituto de Investigaciones en Microbiología y Parasitología Médica, Facultad de Medicina, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (IMPaM, UBA-CONICET), Buenos Aires, Argentina. Electronic address: ppetray@yahoo.com.

Publikováno v: Microbial pathogenesis [Microb Pathog] 2023 Oct; Vol. 183, pp. 106327. Date of Electronic Publication: 2023 Aug 26.

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Autor: Vaitaitis GM; Webb-Waring Center, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, C322, Aurora, CO, USA.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Olmstead MH; Aurora, USA.; PAREXEL International, Waltham, MA, USA., Waid DM; Webb-Waring Center, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, C322, Aurora, CO, USA.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Carter JR; Webb-Waring Center, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, C322, Aurora, CO, USA.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Salem, USA., Wagner DH Jr; Webb-Waring Center, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, C322, Aurora, CO, USA. david.wagner@ucdenver.edu.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. david.wagner@ucdenver.edu.

Publikováno v: Diabetologia [Diabetologia] 2019 Sep; Vol. 62 (9), pp. 1730-1731. Date of Electronic Publication: 2019 Jul 08.

CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Autor: Vaitaitis GM; The Webb-Waring Center, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Waid DM; The Webb-Waring Center, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Yussman MG; The Webb-Waring Center, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Wagner DH Jr; The Webb-Waring Center, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Division of Pulmonary Sciences and Critical Care, Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Publikováno v: Immunology [Immunology] 2017 Oct; Vol. 152 (2), pp. 243-254. Date of Electronic Publication: 2017 Jun 19.

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.

Autor: Vaitaitis GM; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.; Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America., Yussman MG; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.; Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America., Waid DM; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.; Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America., Wagner DH Jr; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.; Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.

Publikováno v: PloS one [PLoS One] 2017 Feb 13; Vol. 12 (2), pp. e0172037. Date of Electronic Publication: 2017 Feb 13 (Print Publication: 2017).

Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Autor: Waid DM; Webb-Waring Center and Department of Medicine, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States., Schreiner T; Department of Neurology, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States., Vaitaitis G; Webb-Waring Center and Department of Medicine, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States., Carter JR; Webb-Waring Center and Department of Medicine, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States., Corboy JR; Department of Neurology, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States., Wagner DH Jr; Webb-Waring Center and Department of Medicine, University of Colorado Denver Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO 80045, United States. Electronic address: David.Wagner@ucdenver.edu.

Publikováno v: Journal of neuroimmunology [J Neuroimmunol] 2014 May 15; Vol. 270 (1-2), pp. 75-85. Date of Electronic Publication: 2014 Mar 15.